Key Points
New Delhi: An eye drop that promises to replace reading glasses for a majority of people with presbyopiaan age-related blurry eye condition which makes it difficult to focus on nearby objectswas launched in India Tuesday, two years after the launch of a similar eye solution in the US..
The eye drop, launched under the brand name PresVu by Entod Pharmaceuticals, a Mumbai-based pharmaceutical firm that specialises in ophthalmological drugs, contains 1.25 percent pilocarpine hydrochloride as the active pharmaceutical ingredient (API) ...
The medicine will work by reducing the size of the pupil, which contracts certain muscles in the eye to help people see up close.The API in the eye solution is a cholinergic agonista group of medicines that mimic the actions of acetylcholine, one of the most common neurotransmitters in the human body that is also linked with the functioning of key muscles in the eyes...
Also, results from the trial have shown that it will be beneficial mostly to people aged 40-55 years and not in people with severe presbyopia.Adjuvants in PresVu have been added keeping in mind the Indian population, which has more pigmented irises, Masurkar said.. Results from clinical trials of PresVu in the Indian population have not been made public...
A senior ophthalmologist with the All India Institute of Medical Sciences (AIIMS) in Delhi, who requested anonymity, told ThePrint that while the eye drop sounds promising, and pilocarpine is a trusted eye solution for many conditions, it remains to be seen whether the compound can be a choice of treatment for people with presbyopia..
